Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To document pre-diagnosis educational abilities, to document any change in educational achievements following treatment, to document educational support given within the statement process and to document the timing of support.
| Condition |
|---|
|
Brain Tumour |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Retrospective |
| Official Title: | Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital, Following the Treatment of a Brain Tumour |
- To compare educational achievements of children of different tumour types following treatment. [ Designated as safety issue: No ]
- To document if there are any differences in educational achievements depending on the age at diagnosis of the brain tumour. [ Designated as safety issue: No ]
| Estimated Enrollment: | 110 |
| Study Start Date: | June 2008 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
This will be a retrospective study. Cases will be identified by looking at the Royal Marsden Hospital (RMH) coding database. All the patients will have completed treatment for a brain tumour. The children all need to have started school before the diagnosis of their brain tumour so that we can look at easily defined educational assessments in this cohort. Children will be identified by looking at RMH coding of diagnosis and include children aged between 4 years and 18 years old (school age).
Eligibility| Ages Eligible for Study: | 4 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Cases will be identified by looking at RMH coding database. Medical information will be sort from the electronic patient records (EPR) and from the patient notes.
Inclusion Criteria:
- patients/parental consent for RMH accessing educational information from them and their school
- patients with a primary brain tumour
Exclusion Criteria:
- children with secondary brain tumours
- children who have had treatment for a relapse of primary brain tumour
Contacts and Locations| Contact: Dr Darren Hargrave | 0208642 6011 | darren.hargrave@rmh.nhs.uk |
| Contact: Dr Antoinette Anazodo | 0208642 6011 | antoinette.anazodo@rmh.nhs.uk |
| United Kingdom | |
| The Royal Marsden NHS Foundation Trust | Recruiting |
| Belmont, Surrey, United Kingdom, SM2 5PT | |
| Principal Investigator: Dr Darren Hargrave | |
| Principal Investigator: | Dr Darren Hargrave | Royal Marsden NHS Foundation Trust |
More Information
No publications provided
| Responsible Party: | Dr Darren Hargrave, Royal Marsden NHS Foundation Trust |
| ClinicalTrials.gov Identifier: | NCT00996450 History of Changes |
| Other Study ID Numbers: | CCR2903 |
| Study First Received: | October 15, 2009 |
| Last Updated: | October 15, 2009 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by Royal Marsden NHS Foundation Trust:
|
brain tumour |
Additional relevant MeSH terms:
|
Brain Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site |
Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 21, 2013